相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Caspofungin suppresses zymosan-induced cytokine and chemokine release in THP-1 cells: possible involvement of the spleen tyrosine kinase pathway
Kazuhiro Itoh et al.
TRANSLATIONAL RESEARCH (2021)
Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?
John H. Strickler et al.
CLINICAL CANCER RESEARCH (2021)
FGL2-wired macrophages secrete CXCL7 to regulate the stem-like functionality of glioma cells
Jun Yan et al.
CANCER LETTERS (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2021)
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
Luuk van Hooren et al.
NATURE COMMUNICATIONS (2021)
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages
John de Groot et al.
NEURO-ONCOLOGY (2020)
p120-catenin-dependent collective brain infiltration by glioma cell networks
Pavlo G. Gritsenko et al.
NATURE CELL BIOLOGY (2020)
Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
Ekaterina Friebel et al.
CELL (2020)
The Mincle/Syk/NF-κB Signaling Circuit Is Essential for Maintaining the Protumoral Activities of Tumor-Associated Macrophages
Chunjie Li et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Charge and Size Dual Switchable Nanocage for Novel Triple-Interlocked Combination Therapy Pattern
Rui Yang et al.
ADVANCED SCIENCE (2020)
Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin
Hui Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Correlation of alteration of HLA-F expression and clinical characterization in 593 brain glioma samples
Enshan Feng et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao et al.
NATURE MEDICINE (2019)
G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma
Yuxiang Wang et al.
NATURE COMMUNICATIONS (2019)
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Mauro Poggio et al.
CELL (2019)
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
Jun Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Genetically engineered T cells for cancer immunotherapy
Dan Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Andrew Butler et al.
NATURE BIOTECHNOLOGY (2018)
IMMUNOTHERAPY Cancer immunotherapy and the value of cure
Joseph C. Del Paggio
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment
Gerald Moncayo et al.
NEURO-ONCOLOGY (2018)
Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium
Kenneth Aldape et al.
NEURO-ONCOLOGY (2018)
Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway
Yu Yu et al.
ONCOGENE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
Qingzhu Jia et al.
NATURE COMMUNICATIONS (2018)
The intracellular signalosome of PD-L1 in cancer cells
David Escors et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series
Marc C. Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma
Spyros Darmanis et al.
CELL REPORTS (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Immune Checkpoint in Glioblastoma: Promising and Challenging
Jing Huang et al.
FRONTIERS IN PHARMACOLOGY (2017)
The Mincle ligand trehalose dibehenate differentially modulates M1-like and M2-like macrophage phenotype and function via Syk signaling
Kristel Kodar et al.
IMMUNITY INFLAMMATION AND DISEASE (2017)
Tumor Purity as an Underlying Key Factor in Glioma
Chuanbao Zhang et al.
CLINICAL CANCER RESEARCH (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis
Candice C. Poon et al.
BRAIN (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling
Julia V. Cockle et al.
NEURO-ONCOLOGY (2016)
Safety and antitumour activity of durvalumab plus tremelimumab in non-small-cell lung cancer: a multicentre, phase 1b study
Scott Antonia et al.
LANCET ONCOLOGY (2016)
Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22
Aidong Zhou et al.
NATURE CELL BIOLOGY (2016)
The role of microglia and macrophages in glioma maintenance and progression
Dolores Hambardzumyan et al.
NATURE NEUROSCIENCE (2016)
Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence
Joline S. J. Lim et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer
Mariya O. Krisenko et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A. Rizvi et al.
LANCET ONCOLOGY (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Matias E. Valsecchi
NEW ENGLAND JOURNAL OF MEDICINE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
SYK Is a Candidate Kinase Target for the Treatment of Advanced Prostate Cancer
Veerander P. S. Ghotra et al.
CANCER RESEARCH (2015)
Functional Roles of Syk in Macrophage-Mediated Inflammatory Responses
Young-Su Yi et al.
MEDIATORS OF INFLAMMATION (2014)
Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo
Shweta Joshi et al.
PLOS ONE (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Targeting the SYK-BTK axis for the treatment of immunological and hematological disorders Recent progress and therapeutic perspectives
Seng-Lai Tan et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman et al.
BLOOD (2011)
The Syk kinase as a therapeutic target in leukemia and lymphoma
Dimitar G. Efremov et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
The SYK tyrosine kinase: a crucial player in diverse biological functions
Attila Mocsai et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Diffuse glioma growth: a guerilla war
An Claes et al.
ACTA NEUROPATHOLOGICA (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
分享论文
